Genetic Testing appears to be so important for Intermediate Dry AMD but retina physicians don’t seem to care. Ask your retina doctor if they are familiar with genetic testing for your eye condition and if you can get an order for the test offered by
ArcticDx - Macula Risk PGx. This company has an AMD genetics test that will show the eye alleles that respond poorly to high zinc formulations in certain AREDS2 brands. The finding is that 15 percent of the intermediate dry AMD patients should not be taking take a high zinc AREDS2. brand. Ask your physician why genetic testing is not the norm. Beta carotene was a problem why is a high concentration of zinc in the formula when 15 percent of the AMD population should not be taking such a dose.